Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Vale16S
    Junior Member
    • Jul 2014
    • 4

    reps and analysis

    Hi all!

    I am doing a 16S amplicon analysis on soil samples with 5 different treatments.
    I have 9 replicates per sample.
    I got from illumina base space a file containing all the reads for all different taxonomic levels. Right now I am working on the class one.
    I normalized the reads to the total number of reads. now I would like to verify the variability within my treatment between the reps, and obtain a single data set to work with per traetment.

    Could you suggest me how is the best way to proceed with the analysis testing the variability, for istance, and then combine the sequences coming from the replicates into a unique sample sequence data set?
    Could you suggest me the best method to analyze the variability between my replicates?

    Do you have ideas?

    Thank you very much!
  • fanli
    Senior Member
    • Jul 2014
    • 197

    #2
    Generally you don't want to discard replicate information. All/most of the downstream analyses that you want to do can and should be done with all of your replicates intact.

    See the QIIME tutorial here:


    A PCoA plot stratified by your five different treatments might be a quick and easy way to convince yourself of the reproducibility of your replicates.

    Comment

    • Vale16S
      Junior Member
      • Jul 2014
      • 4

      #3
      Hi,
      Thank you fanli for replying.
      I have a couple of doubts still about reps treatment for 16S sequnecing.
      I didn't mean to discard the replicates data. I would like just to ask how to deal with them.
      I see the PCoA plot as a tool to evaluate the reproducibility of the reps. What will you do then?
      would you combine the replicates reads ? would you sum the replicates reads? how will you proceed in order to obtain treatments sets?

      Thank you a lot!

      Cheers

      Comment

      • fanli
        Senior Member
        • Jul 2014
        • 197

        #4
        I suppose you could combine the replicate reads if you wanted a single list of OTUs for each treatment. What exactly are you trying to compare with your data? If you want to compare your treatments, it makes more sense to compute diversity/population statistics for each replicate and then compare those between treatments (e.g. a 9-vs-9 comparison).

        Comment

        • Vale16S
          Junior Member
          • Jul 2014
          • 4

          #5
          HI FAnli again,
          I would like to compare the treatments, taking into account the intrinsic variability within the samples (due to DNA extraction or due to field).
          I thought to have a single data set per treatment. maybe it is not the right way.
          Which tool will you use for the 9vs9 comparison?
          thnks

          Comment

          • fanli
            Senior Member
            • Jul 2014
            • 197

            #6
            Hi Vale16S,

            I've been using QIIME to compare alpha- and beta-diversity statistics between treatment groups. See http://qiime.org/scripts/compare_alpha_diversity.html.

            From the man page:
            For example, if your mapping file had a category called ‘Treatment’ that separated your samples into three groups (Treatment=’Control’, Treatment=’Drug’, Treatment=‘2xDose’), passing ‘Treatment’ to this script would cause it to compare (Control,Drug), (Control,2xDose), (2xDose, Drug) alpha diversity values. By default the two-sample t-test will be nonparametric (i.e. using Monte Carlo permutations to calculate the p-value), though the user has the option to make the test a parametric t-test
            So you'd be doing a 9vs9 t-test, essentially.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 12:17 PM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...